We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current INAB market cap is 43.72M. The company's latest EPS is USD -0.6932 and P/E is -1.44.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.4M | -7.8M | -7.86M | -7.72M | -7.17M |
| Net Income | -7.4M | -7.8M | -7.53M | -7.72M | -7.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.07M | -8.56M | -14.65M | -28.52M | -30.34M |
| Net Income | -5.13M | -8.56M | -14.65M | -28.52M | -30.01M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 38.38M | 33.04M | 24.68M | 29.72M | 26.21M |
| Total Liabilities | 8.82M | 10.31M | 7.89M | 7.92M | 8.45M |
| Total Equity | 29.56M | 22.73M | 16.79M | 21.8M | 17.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.13M | 20.91M | 42.22M | 33.04M | 33.71M |
| Total Liabilities | 1.48M | 2.59M | 4.04M | 10.31M | 8.77M |
| Total Equity | -9.24M | -16.58M | 38.18M | 22.73M | 24.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -16.17M | -24.12M | -7.44M | -12.78M | -18.49M |
| Investing | -2.44M | -3.71M | -429k | -451k | -528k |
| Financing | 9.24M | 8.99M | 547k | 12.04M | 13.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.8M | -7.13M | -13.51M | -24.12M | -23.34M |
| Investing | 356k | N/A | -309k | -3.71M | -600k |
| Financing | 65k | 24.52M | 32.96M | 8.99M | 27.04M |
| Market Cap | 43.72M |
| Price to Earnings Ratio | -1.44 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.03 |
| Price to Book Ratio | 1.74 |
| Dividend Yield | - |
| Shares Outstanding | 43.29M |
| Average Volume (1 week) | 155.61k |
| Average Volume (1 Month) | 689.07k |
| 52 Week Change | -29.87% |
| 52 Week High | 3.48 |
| 52 Week Low | 0.65 |
| Spread (Intraday) | 0.01 (0.99%) |
| Company Name | IN8bio Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.in8bio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
